Business Wire

WEBHELP

24.3.2021 10:02:14 CET | Business Wire | Press release

Share
‘The Nest’ by Webhelp expands across Europe

The leading global customer experience (CX) and business solutions provider, Webhelp has announced the expansion of its program, The Nest by Webhelp , across Europe which aims to support startups and scaleups to provide the best-in-class customer experience. The Nest enables fast-growing companies across all sectors to grow exponentially by offering a unique, tailor-made outsourced CX proposition.

This news comes at a time when many young companies are facing multiple challenges due to the pandemic and are requiring flexibility and ROI optimization while uncertainly prevails in their business environments.

Chloe de Mont-Serrat, Head of The Nest, said: “We’re delighted to expand our offering to companies across Europe. Thriving startups have one key thing in common - exceptional customer experience. Outsourcing CX with a trusted partner can enable businesses to scale up quickly while maximizing ROI, freeing them up to focus on what matters most - growing their business.”

Launched in France in 2018, the program already supports dozens of the most dynamic startups, many of which have been placed highly in The French Tech Next rankings . In addition to this, Webhelp is a long-standing partner for countless unicorn startups and is well-placed to help fast-growth companies differentiate their businesses. The program is taking on a European dimension by expanding into the UK, Spain, Germany, The Nordics, The Netherlands, and Turkey.

“We’re excited to launch The Nest in the Nordics to help local startups build an exceptional customer experience. We understand that startups face many complex challenges during the early stages of growth, from developing expertise and processes to support long-term growth to expanding rapidly in new markets and building innovative products and services to differentiate from the competition,” added Victor Sundén, Chief Commercial Officer, The Nest, Nordics.

The Nest by Webhelp makes the expertise of Webhelp, the European market leader for CX, available to smaller businesses and is based on a strong people-first working culture. Its core focus is to support its clients as they grow their businesses and enable them to generate competitive advantages in the CX space. The program offers a wide variety of services, all of which can be customized to the client’s individual needs, including, but not limited to; omnichannel customer engagement services (including customer care, community management and technical support), sales support (customer acquisition & retention, sales assistance) and digital services (content management, moderation services, digital marketing). The program operates 24 hours a day, seven days a week and is available in more than 40 languages.

In addition to a best-in-class customer experience delivered by expert teams, clients also get access to ‘The Nest Community.' This resource will offer members mentoring, business development, and networking opportunities as an additional way to generate traction and achieve better results through a strategic startup network.

As Charles Egly, CEO of Younited Credit , and one of the first startups to join The Nest by Webhelp program, testified: "In the early days of a startup, the senior team often try to tackle all the issues head-on, sometimes to the detriment of the final product or service. The outsourced support that The Nest program offers was invaluable to expand our team and provide reinforced expertise. It also allowed us to conquer new markets much faster. Working with an outsourced partner in this way offers increased efficiency, lower operating costs, more flexibility, and faster time-to-market. Not to mention, access to the best processes and tools on the market, most of which are usually too costly for a startup.”

Webhelp Co-Founder, Olivier Duha, concluded: "We are thrilled that - despite the COVID-19 pandemic - the startup world is still booming, and the pace of fundraising has not slowed down. Ultimately, supporting fast growing startups has always been in our DNA, as we still have an entrepreneurial culture that perfectly guides that.”

END

About The Nest

The Nest by Webhelp is an outsourced customer experience (CX) program by Webhelp to help startups and fast-growth companies differentiate themselves and scale-up their team, quickly and simply. Operating across Europe, the program provides clients access to its global network of operational customer experience specialists 365 days a year and seven days a week. The Nest offers a wide variety of services, all of which are customized to the client’s individual needs, including, but not limited to; omnichannel customer engagement services (including customer care, community management and technical support), sales support (customer acquisition & retention, sales assistance) and digital services (content management, moderation services, digital marketing). Clients of The Nest will have access The Nest Community, offering mentoring and other business support and guidance to enable startups to grow and succeed in their marketplace.

More information can be found at thenest.webhelp.com

About Webhelp

Making business more human for the world’s most exciting brands

We live in an era of fast connectivity and AI. Today, human experiences have even more power to make businesses come to life in customers’ hearts and minds. Webhelp is committed to making business more human. It’s through this commitment that Webhelp enriches customer experience, and designs business solutions that create value for the world’s most exciting companies. Webhelp is a partner across a range of services including customer experience solutions, social media moderation through to payment services. Hundreds of brands across the world trust Webhelp because of their people, the culture they work in, and the ideas and technology they put to work. Webhelp believes that Emotional Intelligence creates a lasting impact, and their skill in marrying a differentiating human touch to the right technology is what makes a real difference for their clients. By choosing Webhelp they access the passion and experience of more than 75,000 game-changers from more than 150 locations in over 50 countries. Each one determined to bring their own intelligence, empathy and experience to the table every day. Webhelp invests in people and the environment they work in, because they know that when people thrive, it has a powerful impact on them, their customers and on their partners’ business. Webhelp believes that making business more human leads to a better customer experience - and a healthier bottom line. Webhelp is the European leader in their industry, with a revenue of more than €1,6B in 2020, and aims for a global leadership position. Webhelp is currently owned by its management and GBL, a leading global investment holding, as of November 2019.

More information can be found at www.webhelp.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye